La Jolla Pharmaceutical Company (LJPC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.7600+0.2600 (+7.43%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 3.5000 |
| Open | 3.5300 |
| Bid | 3.7100 x 800 |
| Ask | 3.7700 x 1000 |
| Day's Range | 3.5300 - 3.7700 |
| 52 Week Range | 3.3500 - 7.8500 |
| Volume | 190,349 |
| Avg. Volume | 243,301 |
| Market Cap | 96.07M |
| Beta (5Y Monthly) | 2.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5990 |
| Earnings Date | Aug 04, 2021 - Aug 09, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.17 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Zacks
La Jolla Pharmaceutical (LJPC) Misses Q1 Earnings Estimates
La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of -37.31% and 2.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress
La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial results for the three months ended March 31, 2021 and highlighted corporate progress.
- Simply Wall St.
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Insiders Increased Their Holdings
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
© 2021 Verizon Media. All rights reserved.
